Skip to main content
Caplight Logo









xFOREST Therapeutics Co., Ltd.

xFOREST Therapeutics Co., Ltd.

Private
KyotoHealthcare & Life Scienceshttps://www.xforestx.com/

Last Round

Series A

Jan 24, 2025

Est. Valuation

$54.34M

Total Funding Raised

$13.16M

Company Overview

xFOREST Therapeutics Co., Ltd. is a biotechnology company that develops small molecule drug discovery platforms targeting RNA structures.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

RNA drug discoverysmall moleculehigh-throughput screeningHTSRNA targetingdrug discovery platformin silicosplicing modulationbiotechnologyundruggable targetsbioinformaticsRNA therapeuticshit-to-leadai drug discoverycomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

xFOREST Therapeutics Co., Ltd. Comparables

Compare xFOREST Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.

xFOREST Therapeutics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Reborna Biosciences, Inc.
88%
Ribometrix
87%
Arrakis Therapeutics
85%

xFOREST Therapeutics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 24, 2025
SeedOct 6, 2020
AcceleratorJan 8, 2020

Key People

Founding team and executive leadership

Richard Kaoru Komatsu

Founder, Representative Director, Chief Technology Officer

Founding Team

Ken Tajiri

Chief Operating Officer, Head of Business Development Division

Executive Team

xFOREST Therapeutics Co., Ltd. Investors

Notable investors and investment history

xFOREST Therapeutics Co., Ltd. investors
InvestorRounds
Open Network LabAccelerator
ANRI株式会社Seed
Miyako CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2025

    Grew 17% QoQ, from 18 to 21 employees.

  • Jul 22, 2025

    Grew 31% QoQ, from 16 to 21 employees.

xFOREST Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

xFOREST Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about xFOREST Therapeutics Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKyoto
Employee Range19
Year Founded2020
Last FundingJan 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?